SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

8.68
Delayed Data
As of Mar 27
 +0.14 / +1.64%
Today’s Change
4.24
Today|||52-Week Range
9.65
-0.91%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +3.69% increase from the last price of 8.68.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in SciClone Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.10
Sales
$34.7M
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 35.71%
 
 
 
 
 
 
Growthannually 18.75%
 
 
 
 
 

Sales

Growthquarterly -16.32%
 
 
 
 
 
 
Growthannually 14.88%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account